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Jo-Anne Chuck’, Michael McPherson’, Hai Huangl, John R Jacobsen2, 
Chaitan Khosla21314 and David E Cane’ 
Background: Modular polyketide synthases (PKSs) are large multifunctional 
proteins that catalyze the biosynthesis of structurally complex bioactive 
products. The modular organization of PKSs has allowed the application of a 
combinatorial approach to the synthesis of novel polyketides via the 
manipulation of these biocatalysts at the genetic level. The inherent specificity 
of PKSs for their natural substrates, however, may place limits on the spectrum 
of molecular diversity that can be achieved in polyketide products. With the aim 
of further understanding PKS specificity, as a route to exploiting PKSs in 
combinatorial synthesis, we chose to examine the substrate specificity of a 
single intact domain within a bimodular PKS to investigate its capacity to utilize 
unnatural substrates. 
Results: We used a blocked mutant of a bimodular PKS in which formation of 
the triketide product could occur only via uptake and processing of a synthetic 
diketide intermediate. By introducing systematic changes in the native diketide 
structure, by means of the synthesis of unnatural diketide analogs, we have 
shown that the ketosynthase domain of module 2 (KS2 domain) in 
6-deoxyerythronolide E? synthase (DEBS) tolerates a broad range of variations 
in substrate structure, but it strongly discriminates against some others. 
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Conclusions: Defining the boundaries of substrate recognition within PKS 
domains is crucial to the rationally engineered biosynthesis of novel polyketide 
products, many of which could be prepared only with great difficulty, if at all, by 
direct chemical synthesis or semi-synthesis. Our results suggest that the KS2 
domain of DEBSl has a relatively relaxed specificity that can be exploited for the 
design and synthesis of medicinally important polyketide products 
Introduction 
Polyketides represent a growing family of natural products 
that exhibit a wide array of biological properties, including 
antibiotic, antiparasitic, antifungal, immunosuppressive and 
antitumor activities [l]. Each polyketide is synthesized 
through the repetitive condensation of simple monomers in 
a manner analogous to fatty acid biosynthesis [2,3]. Poly- 
ketide synthases (PKSs) introduce structural diversity in 
their enzymic products by using a variety of organic-acid 
extender units and controlling the degree of B-carbonyl 
reduction after each successive chain extension. The PKS 
also exhibits high stereochemical control over the new 
chiral centers formed during polyketide-chain elongation, 
while maintaining regioselectivity in the final lactone ring 
cyclization [4]. 
The factors which control the ultimate structure of a PKS 
product have been the object of intensive study, most 
notably through the manipulation of 6-deoxyerythronolide 
B synthase (DEBS), the PKS which catalyzes the biosyn- 
thesis of h-deoxyerythronolide B (6-dEB; 1; Figure l), the 
parent macrolide aglycone of erythromycin [5]. The key to 
much of this effort has been the discovery that the struc- 
tural genes responsible for 6-dEB synthesis consist of 
three contiguous open reading frames (of -10 kb each), 
encoding three large multidomain proteins (-3000 amino 
acids each) designated DEBSl, DEB% and DEBS3 [6,7]. 
Each DEBS protein contains two functional units known 
as modules and each module in turn contains all the active 
sites required for one cycle of condensation and B-carbonyl 
processing. Unlike a typical fatty acid synthase (FAS) that 
uses the same set of active sites for repetitive rounds of 
chain elongation and reductive processing, the PKS multi- 
enzyme assembly carries a distinct active site for each 
individual catalytic step in carbon-chain formation and 
modification. The modular PKS can also control the level 
of B-ketoreduction through the presence of all, some, or 
none of the ketoreductase (KR), enoyl reductase (ER) and 
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Figure 1 
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Modular organization of the multidomain PKS, 
6-deoxyerythronolide B synthase (DEBS). The 
complete DEBS system is composed of three 
large multifunctional polypeptides (each with a 
molecular weight > 300 kDa) designated 
DEBSl, DEBS2 and DEBSB. Each DEBS 
subunit consists of two functional modules, 
each consisting of the active sites required for 
one round of polyketide-chain elongation and 
any necessary reduction and modification of 
the P-keto function. DEBSl +TE is an 
engineered protein which consists of DEBSl 
fused to the thioesterase domain of DEBSS. 
The biosynthesis of 6-deoxyerythronolide B 
(1) from propionyl-CoA, methylmalonyl-CoA, 
and NADPH is catalyzed by DEBSl , DEBSP, 
and DEBSB. DEBSl +TE catalyzes the 
formation of the Cs-triketide lactone 
(2R,3S,4S,5/?)-2,4-dimethyl-3,5-dihydroxy- 
n-heptanoic acid 6 lactone (2) from the same 
three substrates. Abbreviations are as follows: 
ACP, acyl carrier protein, AT, acyltransferase; 
DH, dehydratase, ER, enoyl reductase; KR, 
P-ketoreductase; KS, P-ketoacyl-ACP 
synthase; SNAC, N-acetyl cysteamine 
thioester; TE, thioesterase. 
dehydratase (DH) domains, all of which are present in a 
vertebrate FAS. 
Previous results have shown that the modular arrangement 
of the PKS can be exploited to create a wealth of novel 
products through domain inactivation [7-91, module dele- 
tion [lo-131, domain replacement [14,15], and domain 
insertion ([ 16,17]), whilst maintaining the catalytic integrity 
of the enzyme. Although this powerful technique has paved 
the way towards the rational design of new compounds by 
combinatorial biosynthesis [18,19], proper exploitation of 
the biosynthetic power of modular PKSs to create novel 
metabolites with wide structural diversity requires an 
understanding of the balance between the intrinsic speci- 
ficity and the structural permissiveness of the individual 
catalytic domains. 
Our aim was to probe the structural features that are impor- 
tant in molecular recognition and processing of chain-elon- 
gation intermediates by a modular PKS. With this in mind, 
we decided to explore the limits of substrate specificity 
exhibited by a single PKS domain. DEBSl+TE is an engi- 
neered bimodular PKS in which the thioesterase (TE) 
domain of DEBSS has been fused to the carboxyl terminus 
of DEBSl. DEBSl+TE catalyzes the formation of triketide 
lactone 2 (Figure 1) from one equivalent of propionyl-CoA 
and two equivalents of methylmalonyl-CoA, plus two 
equivalents of NADPH [20,21]. In the absence of propi- 
onyl-CoA, DEBSl+TE can supply its own primer via the 
enzyme-catalyzed decarboxylation of methylmalonyl-CoA 
[Z&23]. The DEBSl+TE mini-PKS is also capable of 
processing 3 (Figure l), the N-acetyl cysteamine (NAC) 
thioester of an advanced diketide intermediate to the 
corresponding triketide lactone 2 [22,23]. Radiolabeling 
studies have identified the specific site of transacylation 
by the diketide 3 as the active-site cysteine of KS?, the 
B-ketoacyl-acyl carrier protein synthase (B-ketoacyl-ACP) 
domain in module 2 of DEBSl [24]. 
We have prepared and kinetically tested a series of diketide 
analogs in order to establish the structural basis of sub- 
strate recognition and the intrinsic limits of molecular dis- 
crimination by the KS2 domain. By using a blocked 
mutant of DEBSl+TE - DEBSl+TE(KSlO) - in which 
the B-ketoacyl-ACP synthase domain of module 1 (KSl) 
has been inactivated by mutation of the active-site cys- 
teine to alanine [24,25], we could effectively isolate the 
KS2 domain for study by abolishing competition with the 
natural biosynthetic route. 
Results and discussion 
Design and synthesis of target diketide analogs 
In order to identify specific regions of molecular recogni- 
tion by the KS2 domain, we systematically examined fea- 
tures of the native diketide structure that we thought 
would be crucial for recognition and processing by its 
cognate active site, namely chain length, stereochemistry, 
and the presence of individual substituents or functional 
groups. We chose five diketide analogs, 4-8 (Figure Z), 
which fulfilled these requirements. Diketides 4 and 5 
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Both DEBSl +TE and DEBSl +TE(KSl O), an engineered mutant of 
DEBSl +TE containing an inactive KS1 domain, can accept the 
N-acetyl cysteamine (NAC) thioester of the diketide 3 and incorporate 
it into the triketide lactone 2. Compounds 4-l 3 represent the various 
diketide NAC thioester analogs used in this study and the 
corresponding triketide products expected from successful processing 
by the DEBSl +TE(KSla) enzyme. Dashed arrows indicate lack of 
conversion of the diketide substrates 7 and 8 to the expected products 
12 and 13. 
retain the stereochemistry of the natural diketide but 
differ in the length of the carbon chain by one fewer or 
one additional methylene unit, respectively. Diketides 6 
and 7 are analogs of the natural diketide substrate lacking 
either the Z-methyl group or the 3-hydroxyl substituent. 
Diketide 8 is a diastereomer of the natural diketide 3 in 
‘v-i, 
6 14 I 11 
iii 
9H 
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Synthesis of diketides 6 and 8 and triketides 11 and 13. For 
experimental details, see the Materials and methods section. 
Conditions: i, LiOH.H,O, H,O,, THF:H,O (2:1), room temperature, 
1.5 h; ii, N-acetylcysteamine, EtsN, Ph,P(O)N,, DMF, 0°C + room 
temperature, 24 h; iii, lithium diisopropylamide, Mel, THF:hexamethyl- 
phosphoramide (4:1), 0°C 15 min then -60°C -+ room temperature, 
12 h; iv, t-butyldimethylsilyl trifluoromethanesulfonate, EtsN, CH,CI,, 
0°C --f room temperature, 2.5 h; v, diisobutylaluminium, CH,CI,, 
-78%, 45 min; vi, di-n-butylboron triflate, I-Pr,EtN, (4R)-3-propionyl- 
4-benzyl-2-oxazolidinone, CH,CI,, 0°C 15 min then -78°C 2 h and 
0°C 1.5 h; vii, t-butyldimethylsilyl trifluoromethylsulfonate, ;-Pr,EtN, 
CH,CI,, 0°C + room temperature, 12 h; viii, LiOH.H,O, H,O,, 
THF:H,O (3:l) 0°C + room temperature, 12 h; ix, 49% aqueous HF, 
CH,CN:H,O (3:1), room temperature, 12 h. 
which the stereochemistry of the C-Z methyl group has 
been inverted. 
Diketide 6 and an authentic sample of the expected 
product, 4-normethyltriketide lactone 11, were synthesized 
from commercially available (-)-methyl (R)-3-hydroxyvaler- 
ate (14; Figure 3). The required sample of 8 was prepared 
by stereoselective methylation [26] of 14, to give (ZR,3R)-15 
(Figure 3) in 84% diastereomeric excess over the (2S,3R)- 
isomer, followed by routine conversion to the NAC thio- 
ester 8. The corresponding 4-epi-triketide lactone 13 (see 
Figure 3) was prepared from 15 by the chiral oxazolidinone 
method of Evans et ul. [27], as described previously [ 10,23, 
281. All other diketide substrates and the corresponding tri- 
ketide lactone derivatives were synthesized using methods 
described previously [10,23,28]. 
In vitro formation of polyketides catalyzed by 
DEW1 +TE(KSl O) 
The ability of the DEBSl+TE(KSl”) mutant enzyme to 
use both natural and aberrant diketide substrates was 
analyzed in nitro using a radiochemical thin layer chroma- 
tography (TLC) assay [ZZ]. The conversion of NAC-dike- 
tides 4 and 5 to the corresponding Cs- and C,,,-triketide 
lactones has been previously reported [Z&23]. Incubation 
of the Z-normethyl diketide 6 with the KSl” mutant, 
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[Z-me~/zyl-14C]methylmalonyl-CoA, and NADPH, gave the 
corresponding 4-normethyl triketide lactone 11. The iden- 
tity of 11 was confirmed by the addition of synthetic unla- 
beled 11 and recrystallization of the mixture to constant 
radioactivity. Interestingly, 11 is also biosynthesized by a 
mutant of DEBSl+TE in which the acyltransferase 1 
(ATl) domain has been replaced by a malonyl transferase 
from the rapamycin PKS [14]. Incubation of the deoxy- 
diketide NAC thioester 7 with partially purified DEBSl+ 
TE(KSlO), [Z-m&yl-‘“C]methylmalonyl-CoA, and NADPH, 
resulted in the formation of trace amounts of a polar 
radioactive product detected by TLC/phosphoimaging 
that was not present in control experiments. Although 
formation of this compound could be blocked by pre-incu- 
bation of DEBSl+TE(KSl”) with cerulenin, a known 
inhibitor of polyketide biosynthesis, the new band did not 
exhibit the same chromatographic mobility as an authentic 
sample of the predicted 5deoxytriketide product, the 
hydroxyacid 12, and was therefore not examined further. 
The diastereomeric diketide, (2R,3R)-Z-methyl-3-hydroxyl- 
pentanoyl NAC thioester (8) was incubated with DEBSl+ 
TE(KSlO) and the usual co-substrates under the conditions 
described above. Gas chromatography/mass spectrometry 
(GC/MS) analysis using synthetic 4-&-methyl triketide 
lactone 13 as a standard indicated the complete absence of 
13 in the incubation product. (A small amount of 2 was 
generated as a result of the presence of 8% of the natural 
(2S,3R)-3 in the synthetic sample of 8.) 
Having identified the products of the incubations of the 
various diketide analogs, we characterized the kinetic 
behavior of these unnatural substrates. In one series of 
experiments, fixed amount of diketides 3, 4, 5, 6 and 8 
were separately incubated with DEBSl+TE(KSlO) in the 
presence of saturating concentrations of [Z+~e&yl-~~C] 
methylmalonyl-CoA and NADPH and the incubation mix- 
tures were assayed at a series of time intervals up to 2 h, 
during which time the rate of formation of all products 
remained linear. The results of these experiments are 
illustrated in Figure 4. Interestingly, the homologous (25, 
3R)-Z-methyl-3-hydroxyhexanoyl NAC thioester (5) was 
actually processed at a rate 75% faster than that of the 
natural diketide intermediate 3, while the Z-normethyl di- 
ketide (6) was processed at a rate 50% that of 3 (Table 1). 
The shorter chain homolog, (2S,3R)-Z-methyl-3-hydroxy- 
butyryl NAG thioester (4), was slower still, but was never- 
theless turned over at a rate 25% of the natural diketide. 
Finally, as expected from the results above, the epimeric 
(2R,3R)-Z-methyl-3-hydroxypentanoyl NAC thioester (8) 
was completely inactive as a substrate. 
To quantify more precisely the level of selectivity for each 
intermediate analog, a series of competition experiments 
was carried out in which the individual diketides 4, 5, and 
6 were incubated with DEBSl+TE(KSlO) in the presence 
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Time-course for triketide synthesis from the various diketide NAC 
thioester analogs catalyzed by DEBSl +TE(KSlO). Incubation mixtures 
(100 ~1) contained the following concentration of substrates: diketide 
NAC thioester (5 mM), [2-mefhy/-14C]-methyImalonyl-CoA (specific 
activity 5mCi/mmol, 100 PM) and NADPH (1 mM). A typical incubation 
contained a DEBSl +TE(KSlO) protein concentration of -0.1 FM, 
determined as described previously [21]. 
(Figure 5). The relative V,,,/K, (where V,,, is maximum 
rate and K,, is the Michaelis constant) for each analog 
could be calculated from the relative rates of formation of 
the corresponding triketide lactone products, after correc- 
tion for the initial concentration of each substrate 
(Table 1). Once again, homolog 5 was found to be mod- 
estly preferred, with a V,,,/K, 1.55 times that of the 
native diketide, while DEBSl+TE(KSl”) showed a 12- 
fold preference for 3 over the truncated diketide analog 4 
(Figure Sa). Interestingly, earlier experiments showed that 
DEBSl+TE has a 8:i preference for the natural starter 
propionyl-CoA over butyryl-CoA, the precursor of the 
enzyme-bound diketide intermediate corresponding to 5, 
whereas a 351 preference in V,,;/K, has been measured 
for propionyl-CoA over acetyl-CoA, the precursor of the 
enzyme-bound equivalent of 4 [Z&23]. In contrast, when 6 
was incubated with the KSl” mutant the absence of the 
Z-methyl substituent resulted in only a sixfold reduction in 
V,,,/K, compared to the value for the incubation with 3. 
In a third set of experiments, the steady-state kinetic para- 
meters were determined for the two most active substrates 
of DEBSl+TE(KSlO), 3 and 5 (Table 1). The native di- 
ketide 3 had a K, of 2.7 ? 0.6 mM and a k,,, of 0.54 
+ 0.07 min-‘, while the higher homolog 5 had a K, of 2.2 
f 0.2 mM and a slightly enhanced k,,, of 0.85 + 0.03 min-‘, 
consistent with the results of the above-described compe- 
tition experiments. The K, for 3 with DEBSl+TE itself 
was also estimated to be in the millimolar range, although 
more precise determination of the steady state parameters 
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Table 1 Figure 5 
Steady state kinetic parameters for the turnover of diketide- 
SNAC analogs into their corresponding triketide lactones. 
Kill k cat vo* “m&m 
Diketide (mM) (min-‘) (pmollmin) V,(re’) (rel)+ 
SNAC 2.7 0.54 2.2 100 100 
SNAC n.d. n.d. 0.6 25 a 
SNAG 2.2 0.85 3.9 175 155 
‘SNAC nd. n.d. 1.1 50 15 
6 
*Initial rates were determined using diketide concentrations of 5 PM 
(Figure 4); +V,,/K, values were determined from competition assays 
(Figure 5); n.d., not determined. 
for diketide substrates of DEBSl+TE was precluded by 
competing triketide synthesis as a result of the endoge- 
nous generation of the propionyl-CoA starter by decar- 
boxylation of methylmalonyl-CoA. In conjunction with 
our earlier findings, the current results suggest that an 
active site or sites other than the loading AT domain are 
responsible for the starter-substrate selectivity exhibited 
by DEBSl and its derivatives. It is also evident that while 
module 1 of DEBSl may discriminate against substrates 
other than propionyl-CoA, this discrimination is attenu- 
ated when the resulting intermediates are processed by 
the KS2 of module 2. Indeed, the butyryl-derived homo- 
log 5 is actually modestly preferred over the natural dike- 
tide intermediate, both in terms of a somewhat lower K, 
and a slightly higher k,,,. 
The fact that the turnover of the natural diketide 3 to give 2 
is -lo-fold slower than the formation of the same triketide 
lactone from propionyl-CoA catalyzed by DEBSl +TE may 
reflect a combination of several factors, including the fol- 
lowing: the diketide-chain elongation intermediate is nor- 
mally generated as an enzyme-bound thioester covalently 
attached to the pantetheinyl residue of ACPl. This inter- 
mediate is thought to undergo direct transfer to the active- 
site cysteine of the KS2 domain. This internal transfer is 
likely to be more rapid than acylation of the same active- 
site cysteine by exogenously added diketide thioesters. In 
addition, IX-acetylcysteamine thioesters are often processed 
less efficiently by fatty acid synthase component enzymes 
than are the natural ACP or CoA substrates [29]. Finally, 
and least likely, the DEBSl+TE(KSlO) mutant may gener- 
ate triketide lactone at an inherently slower rate than does 
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Competition of diketide NAC thioesters for DEBSl +TE(KSI O) 
(a) Competition of diketide NAC thioester 4 and ‘natural’ diketide NAC 
thioester 3 as substrates for DEBSl +TE(KSlO). Incubation mixtures 
contained 4 (5 mM) and 3 (0.5 mM), [2-methy/-i4C]methylmalonyl-CoA 
(specific activity 5 mCi/mmol, 100 PM) and NADPH (1 mM). The 
concentrations of Cs-triketide lactone 2 and Cs-triketide lactone 9 
synthesized in the same reaction are plotted versus time. Rates were 
calculated from the linear range of the data. (b) Competition of 
diketide NAC thioester 5 and NAC thioester 3 as substrates for 
DEBSl +TE(KSl O). Incubation mixtures contained 5 (1 mM) and 3 
(0.85 mM), [2-methy/-14Cl-methylmalonyl CoA (specific activity 
5 mCi/mmol, 100 PM) and NADPH (1 mM). The concentrations of 2 
and C,,-triketide lactone 10 synthesized in the same reaction are plotted 
versus time. Rates were calculated from the linear range of the data. 
For purposes of comparison, we also measured the K, of the 
co-substrate methylmalonyl-CoA using DEBSl+TE(KSlO). 
In the presence of saturating concentrations of diketide 3, 
(ZRS)-methylmalonyl-CoA was found to have a K,, of 19.1 
? 3.9 pM. Because DEBS has been shown to have a strict 
specificity for (ZS)methylmalonyl-CoA [21,30], the actual 
K, for the natural ZS-enantiomer is calculated to be 
9.5 pM, assuming no competition from the inactive (ZR)- 
methylmalonyl-CoA. These values are in excellent agree- 
ment with the K, of 24 @I previously determined for 
(ZRS)-methylmalonyl-CoA and DEBSl+‘I‘E, suggesting 
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that the KSl” mutation has not significantly disturbed the Figure 6 
interaction of the PKS with the methylmalonyl-CoA sub- 
strate. The fact that the diketide-NAC thioesters exhibit 
K, values that are two orders of magnitude higher than 
those for methylmalonyl-CoA (and probably propionyl- 
CoA) is more than likely to be a reflection of the signifi- 
cantly higher effective molarity of the covalently bound 
diketide-ACPl intermediate, as well as a preference for 
the pantetheinyl thioester over the NAC analog. Additional diketide and triketide substrates of DEBS. 
The two inactive diketide analogs - 7, lacking the 
3-hydroxy substituent of the natural chain-elongation 
intermediate, and the Z-&-methyl diketide 8 - were 
each tested as inhibitors of triketide lactone formation in 
the presence of the natural diketide 3. Incubation of 
DEBSl+TE(KSl”) with diketide 3 in the presence of 
lo-fold higher concentrations of either 7 or 8, along with 
[Z-me&&14C]methylmalonyl-CoA and NADPH, had no 
detectable effect on the observed rate of formation of 2. 
These results indicate that both the presence of the 
hydroxyl moiety and the stereochemistry at C-Z of the 
diketide are essential for molecular recognition of the 
native diketide intermediate by the KS2 domain. 
Molecular recognition and specificity of the KS2 domain 
The data reported here, in combination with the results of 
earlier studies, have provided a detailed picture of the 
selectivity of DEBS module 2 for a wide spectrum of di- 
ketide substrates. Of the three catalytic domains - KS?, 
KRZ, and the appended TE domain -only KS& the 
P-ketoacyl-ACP synthase domain of DEBS module 2, is 
likely to exercise the degree of structural selectivity that 
has been observed. Previous experiments have shown that 
3, the NAC-thioester analog of the natural diketide-chain 
elongation intermediate, covalently acylates the active-site 
cysteine of the KS2 domain [24]. Were this acylation to be 
non-selective, with either the downstream KR2 or TE 
domains exercising the observed selectivity, then we 
would expect that the two inactive diketide analogs, 7 and 
8, would also acylate the active site of KS2 and therefore 
act as irreversible inactivators of DEBSl+TE(KSlO). In 
fact neither 7 nor 8 is an inhibitor of polyketide chain elon- 
gation from 3. Based on the available data, we cannot as yet 
distinguish whether the observed selectivity is primarily 
due to KSZ-catalyzed self-acylation by the diketide, or to 
the subsequent condensation step, or to some combination 
of the two events. In addition, we cannot exclude the pos- 
sibility that either the KR2 or the TE domain, or both, 
influence the observed selectivity, either by positively 
amplifying or negatively modulating the intrinsic specifi- 
city of the KS2 domain. The factors described below affect 
the molecular recognition of diketide substrates by KS2 
Chain length 
KS2 will process diketides with a variety of chain lengths. 
Earlier experiments using acetyl-CoA and butyry-CoA 
starting units had established that DEBS can tolerate a 
range of substrate analogs [ZO-231. The behavior of the 
derived diketides 4 and 5 has now confirmed this observa- 
tion and indicated that in some cases diketide chain 
length homologs can actually be processed at a somewhat 
faster rate than are the natural diketides. We have also 
recently reported in viva experiments, with a mutant of 
the complete DEBS harboring a defective KS1 domain, 
which established the ability of the PKS to process di- 
ketide analogs with even longer starter chains (16) or 
carrying a bulky benzyl substituent (17; [31]; Figure 6). 
Substitution at C-2 
The natural diketide-chain elongation intermediate is 
substituted at C-Z with a methyl group in the L’S configu- 
ration. In the ketosynthase reaction catalyzed by the KS 
domains of DEBS, the introduction of the methylmalonyl 
extender unit is controlled by the corresponding AT 
domain, which has been shown to have a strict require- 
ment for (ZS)methylmalonyl-CoA [21,30]. The condensa- 
tion reaction itself is a decarboxylative acylation with 
inversion of configuration [32]. Replacement of the native 
DEBS AT domains with malonyl-AT domains from a 
variety of heterologous PKS gene clusters [14,33] allows 
the generation of chain-elongation intermediates and 
derived polyketides lacking the usual U-methyl sub- 
stituent. We have now shown that the analog 6, in which 
the U-methyl group has been replaced by a hydrogen 
atom, is processed at a significant rate compared to that of 
the natural intermediate. On the other hand, the diastereo- 
merit diketide 8, in which the methyl group stereochem- 
istry at C-2 has been inverted, is completely inactive as a 
substrate for the KS2 domain. 
C-3 oxygen substituent 
We and others have shown previously that unreduced 
B-ketoacyl thioesters, generated by inactivation of the cor- 
responding KR domains or by the simple omission of 
NADPH from incubation mixtures, are viable substrates 
for downstream condensing (KS) domains [7,22,23]. On 
the other hand, the fact that the 3-deoxydiketide 7 is inac- 
tive as a chain-elongation substrate establishes that an 
oxygen atom at C-3 is normally required for processing by 
the KS2 domain. Interestingly, the unsaturated triketide 
18 has been shown to be processed by the KS2 domain to 
Research Paper Molecular recognition within a bimodular polyketide synthase Chuck et al. 763 
gi\re, ultitnatcly, H 16 membered ring unsaturated octake- 
tide lactone [Al]. ‘I’hus. in the absence of an oxygen atom at 
C.3. the KSZ domain may be able to recognize the alternate 
h~dros)-I substitwnt 3t C-5. 
Significance 
Polyketide synthases (PKSs) are multifunctional proteins 
that catalyze the biosynthesis of a number of medicinally 
important natural products. Their modular arrangement 
allows a combinatorial approach to the synthesis of novel 
polyketides, but the specificity of PKSs for their natural 
substrates ma)- limit the molecular diversity of muta- 
biosynthetic polyketide products. We have analyzed the 
molecular recognition features of a P-ketoacyl-acyl carrier 
protein synthase (KS) domain within a modular PKS and 
identified specific structural features of the natural sub- 
strate that are required by its cognate active site. By using 
a blocked mutant of a himodular PKS, we were able to 
explore the intrinsic specificity limits of the KS2 domain 
as a result of its ability to process unnatural substrate 
analogs into their corresponding polyketide products. 
These findings pave the way for the production of novel 
polyketides through a mutabiosynthetic process that com- 
plements the current methods employed in the rational 
design of new polyketide products. This approach creates 
a new avenue for obtaining the increased molecular diver- 
sit). curreutl?; required in screening for novel compounds 
of medicinal importance. 
Materials and methods 
Materials 
All reactions were run under nitrogen atmosphere using oven-dried 
syringes and flame-dried glassware when appropriate. THF and Et,0 
were distilled from NaIbenzophenone ketyl. CH,CI, was distilled from 
CaH,. Flash column chromatography was performed with EM reagent 
silica gel 60 (230-240 mesh) and the indicated solvent systems. DL-[2- 
methy/-14C]Methylmalonyl-CoA (56.4 mCi/mmol) was obtained from 
ARC, Inc. Methyl (3R)-3-hydroxy valerate was purchased from Fluka. All 
other reagents and solvents were obtained from Aldrich. 
Protein isolation 
Streptomyces coelicolor CH999/pCK16, which expresses DEBSI + 
TE(KSlO), a null mutant of the DEBSI+TE in which the KS1 domain 
has been Inactivated by site-directed mutagenesis [25], was used as a 
source of protein. DEBSI+TE(KSlO) was partially purified by ammo- 
nium sulfate precipitation and gel filtration [34]. The concentration of 
DEBSl +TE(KSIO) was determined by densitometric scanning of 
stained SDS-PAGE gels using myosin as a standard. Adobe Photo- 
shop 2.5.1, NIH Image 1.5.2, and Molecular Analyst (BioRad) software 
packages were used for image analysis and quantification. Typically 
preparations contained 0.2 FM DEBSI +TE(KSlO). 
Assays 
Assays were carried out essentially by the method reported [22]. Unless 
stated otherwise, the various diketide-SNAC (5 mM) were incubated 
with (2RS)-[2-methy/-‘4C]methylmalonyl-CoA (100 PM, 5 mCi/mmol), 
1 mM NADPH and DEBSl +TE(KSlO) (10 pmol) in a final volume of 
100 ~1. After incubation for various time periods (15-l 80 min) at 3O”C, 
the assay mixtures were extracted and products separated by TLC [22]. 
Quantification of radioactive compounds was carried out using a Molec- 
ular lmager GS-363 (BioRad) and authentic [‘%-labeled triketide 
lactone 2 as radioactive standard. Initial velocities were determined by 
linear regression. Kinetic values were determined by varying diketlde 
concentrations from 0.5-l 5 mM and [‘4C]-methylmalonyl-CoA con- 
centrations from 1-l 00 KM. Initial velocities were fitted directly to the 
Michaelis-Menten equation by non-linear least-squares regression 
using standard kinetic software packages and used to calculate K, 
and V,,,. V,,,/K, values were determined from competition assays 
where diketide-SNAC 3 was incubated in the presence of a second 
diketide analog. Except where indicated, each diketide was at a con- 
centration of 1 mM. The ratio of the rate of formation of the two trike- 
tide lactones being synthesized simultaneously in the one assay gave 
the relative V&K,, after adjustment for differences in the two initial 
diketide substrate concentrations. 
Product analysis and characterization 
‘H and 13C nuclear magnetic resonance (NMR) spectra were recorded 
on Bruker WM.250 and AM-400 NMR spectrometers. Chemical shifts 
are reported In parts per million relative to tetramethylsilane. Infra-red (IR) 
spectra were recorded on a Perkin-Elmer 1600 series Fourier transform 
IR (FIR) spectrophotometer. Optical rotations were obtained using a 
Perkin-Elmer 241 Polarimeter using the Na D line at 25°C and are 
reported as follows: [cL]~ (concentration, c, g/l 00 ml, solvent). Mass 
spectra were obtained by chemical ionization or electron ionization using 
a Kratos MS80RFA Mass Spectrometer and are reported as m/z. 
GCYMS was performed on a Hewlett-Packard 5988A mass spectrome- 
ter interfaced to an HP 5890 II capillary gas chromatograph. Optical rota- 
tions were measured on a Perkin-Elmer 241 polarimeter using the Na D 
line at 25°C. The formation of triketide lactones 2, 9, 10 and 11 in incuba- 
tions with DEBSI +TE(KSlO) was confirmed in each case by rectystal- 
lization to constant specific activity with their synthetic counterparts [24]. 
DiketIdes 2 and 13 had identical R, values on TLC and therefore could 
not be resolved by this method. GC/MS analysis was therefore used to 
analyze the product of incubation of Z-ep;-methyl diketide 8 with 
DEBSl +TE(KSlO) and co-substrates. The separation was carried out on 
an HP cross-linked silicone gum capillary column (12.5 m x 0.22 mm x 
0.33 ym) with positive chemical ionization detection (methane) and 
selected ion monitoring at 173 amu. Separation of the triketlde lactone 
epimers was achieved with an oven temperature gradient of 80°C to 
250°C at 25”C/min and a solvent delay of 2 min. Under these conditions 
triketide lactones 2 and 13 had retention times of 5.67 min and 5.54 mln, 
respectively. Only a small quantity of 2 was detected In the incubation 
product, formed as a result of the presence of < 8% 3 in the sample of 8. 
(3R)-3-Hydroxypentanoic acid 
Methyl (3R)-3-hydroxyvalerate (14) (105 mg, 0.80 mmol, 1 .O eq.) was 
dissolved in 4ml of THF and 2 ml of H,O. LiOH.H,O (67 mg, 
1.60 mmol, 2.0 eq.) was added and the reaction mixture was stirred at 
room temperature for 1.5 h. THF was evaporated, the aqueous solution 
was acidified with HCI to pH 2, and then extracted with EtOAc. After 
drying over Na,SO,, evaporation of EtOAc yielded 93 mg of (3f?)-3- 
hydroxypentanolc acid (99%). ‘H NMR (CDCI,): 6 3.95-3.88 (m, lH, 
C(3)-H), 2.62-2.55 (m, 1 H, one of C(2)-H,), 2.55-2.42 (m, 1 H, one of 
C(2)-H,), 1.65-l .49 (m, 2H,C(4)-H,), 1 .Ol (t. 3H, C(5)-H,). 
(3R)-3-Hydroxypentanoic acid N-acetyl cysteamine thioester 6 
To a dry 10 ml three-neck flask was added 60 mg (0.51 mmol, 1 .O eq.) 
of (3R)-3-hydroxypentanoic acid and 5 ml of DMF. The solution was 
cooled to 0°C and 0.28 ml (2.03 mmol, 4 eq.) triethylamine and 0.33 ml 
(1.53 mmol, 3.0 eq.) diphenylphosphoryl azide were added. The reac- 
tion mixture was stirred at 0 “C for 3 h. N-acetylcysteamine (400 mg, 
3.57 mmol, 7 eq.) was added and the reaction mixture was warmed to 
room temperature and stirred for 24 h. The reaction was then quenched 
with 3 ml H,O, extracted with EtOAc, and dried overnight (Na,SO,). 
After evaporation of the solvent, the crude product was purified by SIO, 
column chromatography with 4% MeOH in CH,CI, to afford 47 mg of 6 
as a colorless oil (42%). R,=0.08 (4% MeOH in CH,CI,). ‘H NMR 
(CDCI,): 6 5.85-5.75 (br, lH, N-H), 4.05-3.93 (m, IH, C(3)-H), 3.50- 
3.43 (m, 2H, N-CH*) 3.05-2.99 (m, 2H, S-CH,), 2.78-2.74 (m, 2H,C(2)- 
H,), 1.97 (s, 3H, COCH,), 1.58-I .48 (m, 2H, C(4)-H,), 0.97 (t, 3H, 
C(5)-H,). 
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Methyl (3R)-3-(t-bu(yldimethylsiloxy)-valerate 
A solution of 415 mg (3.14 mmol, 1 .O eq.) methyl-(3R)-3-hydroxyvalerate 
14 in 15 ml CH,CI, was cooled to 0°C under N,. f-Butyldimethylsilyl tri- 
fluoromethanesulfonate (TBDMSOTf; 1.08 ml, 4.70 mmol, 1.5 eq.) was 
added and the mixture was stirred for 10 min, after which 1 .lO ml NEt, 
(7.85 mmol, 2.5 eq.) was added. The reaction was allowed to warm to 
room temperature in 2.5 h before being quenched with brine. The 
aqueous layer was extracted with CH,CI, and the combined organics 
were washed with pH 11 NaOH and dried over Na,SO,. The crude 
product was purified by SiO, column chromatography with 1:9 EtOAc: 
hexanes to afford methyl (3/?)-3-(f-butyldimethylsiloxy)-valerate as a col- 
orless oil (696 mg, 90%). ‘H NMR (CDCI,): 6 4.1 E-4.05 (m, 1 H, C(3)- 
H), 3.68 (s, 3H, OCH,), 2.42-2.40 (m, 2H, C(2)-H,), 1.58-1.48 (m, 2H, 
C(4)-H,), 0.91-0.86 (m, 12H, f-Bu in TBS and C(5)-H,), 0.05-0.02 (m, 
6H, dimethyl in TBS). 
(3R)-3-(t-Butyldimethylsiloxy)-pentanal 
To a flame-dried 25 ml two-neck flask was added 0.307 g (1.35 mmol, 
1 .O eq.) of methyl (3R)-3-(f-butyldimethylsiloxy)~valerate in 6 ml CH,CI,. 
The solution was cooled to -78°C and 1.25 ml of DIBAL-H (1 .O M in 
CH,CI,, 1 .O eq.) was added. The reaction mixture was stirred at -78°C 
for 1 h, then quenched with 3 ml saturated Rochelle salt solution. The 
resulting mixture was then warmed to room temperature and stirred for 
1 h. The aqueous layer was extracted with CH,CI,. The combined 
organic extracts were dried with NazSO, and the concentrated extract 
was purified by flash SiO, column chromatography with I:9 EtOAc: 
hexanes to afford 256 mg (89%) of (3R)-3-(t-butyldimethylsiloxy)-pen- 
tanal as a colorless oil. R,= 0.40 (10% EtOAc/hexanes). ‘H NMR 
(CDCI,): 6 9.82-9.80 (m, 1 H, C(l)-H), 4.20-4.10 (m, lH, C(3)-H), 
2.52-2.49 (m, 2H, C(2)-Hz), 1.60-1.49 (m, 2H, C(4)-Hz), 0.92-0.85 (m, 
12H, t-Bu in TBS and C(5)-H,), 0.06-0.01 (m, 6H, dimethyl in TBS). IR 
(neat; cm-r): 2956, 2885, 2858, 2720, 1728, 1472, 1464. 
(4R)-3-[(2’R,3’S,5’R)-2’-Methyl-3’-hydroxy-5’-t-butyldimethyl- 
siloxy-heptanoyll-4-benzyl-2-oxazolidinone 
To a solution of 358 mg (1.54 mmol, 1.75 eq.) of (4R)-3-propionyl-4- 
benzyl-2-oxazolidinone in 12 ml CH,CI, at 0°C under nitrogen was 
added 1.49 ml di-n-butylboron triflate (Bu,BOTf) (1 .O M in CH,CI,, 
1.7 eq.) followed by the addition of 0.29 ml diisopropylethylamine 
(1.67 mmol, 1.9 eq.). The solution was stirred at 0°C for 50 min, then 
cooled to -78°C and 0.190 g (0.88 mmol, 1 .O eq.) of (3@3-(t-butyl- 
dimethylsiloxy)-pentanal was added. The resulting solution was stirred 
for 2 h at -78°C then for 1.5 h at 0°C before quenching with 12 ml 1 M 
NaOAc in 800/, methanol/water. After 5 min, 3 ml of 30% aqueous 
H,O, was added dropwise. After being stirred at ambient temperature 
for 30 min, the mixture was partitioned between 90 ml water and 
120 ml hexanes. The organic layer was washed with aqueous NaHCO, 
and brine, dried (Na,SO,) and concentrated. Purification by flash SiO, 
column chromatography with 20% EtOAc in hexanes afforded 0.316 g 
(80%) of (4R)-3-[(2’R,3’S,5’R)-2’-methyl-3’-hydroxy-5’-t-butyldimethyl- 
siloxy-heptanoyll-4-benzyl-2-oxazolidinone as a colorless oil. ‘H NMR 
(CDCI,): 6 7.38-7.20 (m, 5H, Ph-H), 4.75-4.65 (m, lH, N-CH), 4.29. 
4.18 (m, 2H, 0-CH,), 4.18-4.07 (m, lH, C(3’)-H), 3.95-3.90 (m, 1 H, 
C(2’)-H), 3.82-3.72 (m, 1 H, C(5’)-H), 3.32-3.26 (m, 1 H, one of Ph- 
CH,), 2.82-2.73 (m, IH, one of Ph-CH,) 1.70-1.57 (m, 2H, C(4’)-Hz), 
1.32-l .20 (m, 5H, C(6’)-H, and C(P’)-CH,), 0.91-0.85 (m, 12H, t-Bu in 
TBS and C(7’)-H,), 0.09-0.07 (m, 6H, dimethyl in TBS). 
(4R)-3-f(2’R,3’S,5’R)-2’-Methyl9’,5’-bis(t-butyldimethyl- 
siloxy)-heptanoyll-4-benzyl-2-oxazolidinone 
To a stirred solution of 0.316 g of (4R)-3-[(2’/?,3’S,5’@2’.methyl- 
3’-hydroxy-5’-t-butyIdimethylsiloxy-heptanoyl]-4-benzyl-2-ox~olidinone 
(0.70 mmol, 1 .O eq.) in 10 ml CH,CI, was added 0.36 ml (1.6 mmol, 
2.3 eq.) of TBDMSOTf at 0°C followed by 0.36 ml (2.0 mmol, 2.8 eq.) 
diisopropylethylamine. The mixture was allowed to warm to room tem- 
perature overnight and was then quenched with brine. The separated 
organic layer was washed with aqueous NaHCO, and brine, dried 
(Na,SO,) and concentrated. Purification by flash SiO, column chro- 
matography with 10% EtOAc in hexanes afforded 0.342 g (85%) of 
(4R)-3-[(2’R,3’S,5’R)-2’-methyl-3’,5’-bis(t-butyldimethylsiloxy)-heptanoyl]- 
4-benzyl-2-oxazolidinone as white crystals. ‘H NMR (CDCI,): 6 7.32- 
7.1 8 (m, 5H, Ph-H), 4.65-4.52 (m, 1 H, N-C-H), 4.1 E-4.09 (m, 3H, 0-CH, 
and C(3’)-H), 4.02-3.95 (m, 1 H, C(2’)-H), 3.65-3.60 (m, 1 H, C(5’)-H), 
3.30-3.26 (m, 1 H, one of Ph-CH,), 1.67-l .54 (m, 2H, C(4’)-Hz), 1.31. 
1 .19 (m, 5H, C(6’)-H, and C(P’)-CH,), 0.94-0.83 (m, 21 H, two f-Bu in 
TBS and C(7’)-H,), 0.1 O-0.02 (m, 12H, two dimethyl in TBS). 
(2R,3S,5R)-2-Methyl-3,5-bis(t-bu~ldimethylsiloxy)-heptanoic acid. 
To a stirred solution of 0.342 g (0.61 mmol, 1 .O eq.) (4R)-3-[(2’/?,3’S, 
5’R)-2’-methyl-3’,5’-bis(f-butyldimethylsiloxy)-heptanoyl]-4-benzyl-2~oxa- 
zolidinone in 11.3 ml THF and 3.8 ml Hz0 at 0°C was added 0.50 ml 
(4.89 mmol, 8 eq.) of H,O, followed by 51 mg (1.22 mmol, 2 eq.) of 
LiOH.H,O. The resulting mixture was warmed to room temperature 
overnight before quenching with 1.7 ml 20% Na,SO,. THF was 
stripped off and the aqueous solution was acidified with 1 N HCI and 
extracted with CHzCI,. The organic solution was dried (Na,SO,) and 
concentrated to afford 0.185 g (76%) of (2R,3S,5/?)-2-methyl-3,5- 
bis(tbutyldimethylsiloxy)-heptanoic-acid as a colorless oil. rH NMR 
(CDCI,): S 4.22-4.14 (m, lH, C(3)-H), 3.80-3.70 (m, lH, C(5)-H), 
2.74-2.67 (m, lH, C(2)-H), 1.80-1.70 (m, 2H, C(4)-Hz), 1.59-1.47 (m, 
2H, C(6)-Hz), 1.20-l .12 (d, 3H, C(P)-CH,), 0.92-0.84 (m, 21 H, two f-Bu 
in TBS and C(7)-H,), 0.1 O-0.02 (m, 12H, two dimethyl in TBS). 
(2R,3S,5R)-2-Methyl-3,5-dihydroxy-n -heptanoic acid 6 lactone 7 1 
To a solution of 0.185 g of (2R,3S,5R)-2-methyl-3,5-bis(f-butyldimethyl- 
siloxy)-heptanoic-acid in 12 ml CH,CN and 2.4 ml Hz0 was added 
1.67 ml of 49% aqueous HF at room temperature. The reaction was 
stirred overnight before quenching with sat. NaHCO,. The mixture was 
extracted with CH,CI, and the organic solution was dried (Na,SO,) 
and concentrated. Purification by SiO, column chromatography with 
50% EtOAc in hexanes afforded 32 mg (55%) of 11 as white crystals. 
Rr= 0.22 (50% EtOAc/hexanes), I H NMR (CDCI,): 6 4.20-4.13 (m, 1 H, 
C&-H), 3.80-3.71 (m, 1 H, C(3)-H), 2.41-2.32 (m, lH, C(2)-H), 2.25. 
2.17 (m, lH, one of C(4)-Hz), 1.82-1.59 (m, 3H, C(6)-Hz and one of 
C(4)-Hz), 1.41 (d, J=6.95 Hz, 3H, C(P)-CH,), 1.00 (t, J= 7.5 Hz, 3H, 
C(7)-H,). 13C NMR (CDCI,): 6 173.4 (C-l), 77.7 (C-5) 70.3 (C-3) 45.1 
(C-2) 37.7 (C-4) 28.8 (C-6), 13.5 (C(2)-CH,), 9.1 (C-7) [c&=+132.0 
(c 1 .13, CHCI,). 
Methyl (2R,3R)-2-methyl-3-hydroxyvalerate 15 
To a flame dried 10 ml two-neck flask containing 0.31 ml (2.23 mmol, 
2.9 eq.) of diisopropylamine at 0°C was added with stirring 1 .14 ml 
n-butyllithium (1.6 M in hexanes, 2.4 eq.). The reaction mixture was 
stirred at 0°C for 20 min before cooling to -60°C. After 15 min, 
0.097 g (0.73 mmol, 1 .O eq.) methyl (3/?)3hydroxyvalerate 14 was 
added. The mixture was held at -60°C for 15 min before being warmed 
to 0°C and stirred for 1 h. CHsI (0.37 ml, 5.8 mmol, 8.0 eq.) and 
0.25 ml HMPA were then added and the reaction was stirred at room 
temperature overnight. After addition of saturated aqueous NH,CI, the 
mixture was extracted with 1 :l hexanes:ethyl ether. The organic extract 
was dried over Na,SO, and purified by flash column SiO, chromatog- 
raphy with 1 :l hexanes:ethyl ether to afford 48 mg (46%) of methyl 
(2/?,3R)-2-methyl-3-hydroxyvalerate 15 as a colorless oil, in 84% dia- 
stereomeric excess over the (2S,3R)-diastereomer, as determined by 
rH NMR on the derived NAC thioester 8. ‘H NMR (CDCI,): 6 3.71 (s, 
3H, 0-CH,), 3.64-3.54 (m, 1 H,C(B)-H), 2.61-2.50 (m, 2H, OH and C(2)- 
H), 1.64-l .53 (m, 1 H, one of C(4)-H), 1.50-l .38 (m, 1 H, one of C(4)-H), 
1.23-1.20 (d, 3H, C(2)-CH,), 0.98-0.95 (m, 3H, C(5)-H,). r3C NMR 
(CDCI,): 176.8, 74.7, 52.1, 44.7, 28.8, 14.8, 9.9. IR (neat; cm-r): 3447, 
2968,2881,1744,1460. 
(2R,3R)-2-Methyl-3-hydroxypentanoic acid 
Methyl (2/?,3/?)-2-methyl-3-hydroxyvalerate 15 (54 mg, 0.38 mmol, 
1 .O eq.) was dissolved in 3 ml THF and 1.5 ml H,O. LiOH.H,O (32 mg, 
0.76 mmol, 2.0 eq.) was added and the reaction mixture was stirred at 
room temperature for 1.5 h. The THF was evaporated and the aqueous 
solution was acidified with 1 N HCI to pH 2, then extracted with EtOAc. 
After drying over Na,SO,, evaporation of EtOAc yielded 40 mg (92%) 
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of (2&U?)-2-methyl-3-hydroxypentanoic acid. ‘H NMR (CDCI,): 6 3.68- 
3.62 (m, lH, C(3)-H), 2.62-2.44 (m, lH, C(2)-H), 1.68-1.45 (m, 2H, 
C(4)-H,), 1.27-l .24, (d, 3H, C(2)-CH,), 1.03-0.97 (t, 3H, C(5)-Ha). 
(2R,3R)-2-Methyl-3-hydroxypentanoic acid NAC-thioester 8 
To a dry 10 ml three-neck flask was added in 40 mg (0.29 mmol, 
1 .O eq.) of (2R,3R)-P-methyl-3-hydroxypentanoic acid and 5 ml DMF. 
The solution was cooled to 0°C and 0.16 ml (1 .16 mmol, 4 eq.) of 
triethylamine and 0.19 ml (0.87 mmol, 3 eq.) of diphenylphosphoryl 
azide were added. The reaction mixture was stirred at 0°C for 3 h. 
N-acetylcysteamine (0.24 g, 0.20 mmol, 7 eq.) was then added and the 
reaction mixture was warmed to room temperature and stirred for 24 h. 
The reaction was then quenched with 3 ml H,O, extracted with EtOAc, 
and the extract was dried over Na,SO,. The crude product was 
purified by SO, column chromatography with 4% MeOH in CH,CI, to 
afford 41 mg (54%) of 8 as a colorless oil. R,=O.14 (4% MeOH in 
CH,CI,). 25”c[cxI,=-21.00 (c 0.29 CHCI,). ‘H NMR (CDCI,): 6 5.83 
(br, 1 H, N-H), 3.69-3.62 (m, lH, C(3)-H), 3.54-3.38 (m, 2H, N-CH,), 
3.07-3.02 (m, 2H, S-CH,), 2.83-2.69 (m, lH, C(2)-H), 2.10 (br, lH, O- 
H), 1.97 (s, 3H, C--O-CH,), 1.66-1.55 (m, lH, one of C(4)-H,), 1.55. 
1.38 (m, 1 H, one of C(4)-H,), 1.24-l .21 (d, 3H, C(P)-CH,), 1 .OO-0.94 (t, 
3H, C(5)-H,). 13C NMR CDCI,: 6 204.1 (C-l), 170.3 (NCO), 75.1 (C-3) 
53.8 (C-21, 39.4 (CH,N), 28.6 (CH,S), 27.7 CHsCO), 23.2 (C-4) 15.1 
(C-P-CH,), 9.7 (C-5). IR (neat; cm-l): 3318, 3088, 2975, 2935, 2878, 
1652,1558,1456,1375. 
Methyl (2R,3R)-2-methyl-3-(t-butyldimethylsiloxy)valerate 
A solution of 0.20 g (1.39 mmol, 1 .O eq.) methyl (2/?,3R)-2-methyl-3- 
hydroxyvalerate 15 in 15 ml CH,CI, was cooled to 0°C under N* and 
0.48 ml of TBDMSOTf (2.09 mmol, 1.5 eq.) was added. The mixture 
was stirred for 10 min, followed by addition of 0.49 ml NEt, 
(3.48 mmol, 2.5 eq.). The reaction was allowed to warm to room tem- 
perature over 2.5 h before quenching with brine. The aqueous layer 
was extracted with CH,CI, and the combined organic extracts were 
washed with pH 11 aqueous NaOH and dried over Na,SO,. The crude 
product was purified by SiO, column chromatography with 1:9 EtOAc: 
hexanes to afford 0.356 g (99%) of methyl (2R,3/?-2-methyl-3-(t-butyl- 
dimethylsiloxy)valerate as a colorless oil. ‘H NMR (CDCI,): 6 3.95-3.88 
(m, lH, C(3)-H), 3.66 (s, 3H, 0-CH,), 2.67-2.62 (m, lH, C(2)-H), 1.55. 
1.44 (m, 2H, C(4)-H,), 1.09-l .06 (d, 3H, C(2)-CH,), 0.92-0.84 (m, 9H, 
t-Bu in TBS and C(5)-H,), 0.07-0.02 (m, 6H, dimethyl in TBS). 13C NMR 
CDCI,: 6 175.6, 74.3, 51.4, 44.9, 25.7, 18.0, 12.2, 8.3, -2.9, -4.4, -5.0. 
IR (neat; cm-‘): 2960, 2886, 2858, 1744, 1464, ,1382, 1351. 
(2R,3R)-2-Methyl-3-(t-butyldimethylsiloxy)pentanal 
To a flame-dried 25 ml two-neck flask was added 1.613 g (6.25 mmol, 
1 .O eq.) of methyl (2R,3R)-2-methyl-3-(t-butyldimethylsiloxy)valerate in 
30 ml CH,CI,. The solution was cooled to -78°C and 6.25 ml DIBAL- 
H (1 .O M in CH,CI,, 1 .O eq.) was added. The reaction mixture was 
stirred at -78°C for 45 min, then quenched with 15 ml saturated 
Rochelle salt solution. The reaction mixture was then warmed to room 
temperature and stirred for 1 h. The aqueous layer was extracted with 
CH,CI, and the combined organic layers were dried over Na,SO, and 
purified by flash SiO, column chromatography with 5% ethyl ether in 
hexanes to afford 0.66 g (45%) of (2f?,3R)-2-methyl-3-(t-butyldimethyl- 
siloxy)pentanal as a colorless oil. R,= 0.3 (5% ethyl ether in hexanes). 
25’cb.lo = -40.0 (c 0.72, CHCI,): ‘H NMR (CDCI,) F 9.76-9.75 (s, 1 H, 
C(l)-H), 3.88-3.84 (m, lH, C(3)-H), 2.58-2.46 (m, IH, C(2)-H), 1.63- 
1.50 (m, 2H, C(4)-H,), 1.08-l .05 (d, 3H, C(2)-CH,), 0.98-0.86 (m, 
12H, f-Bu in TBS and C(5)-H,), 0.06-0.01 (m, 6H, dimethyl in TBS). IR 
(neat; cm-‘): 2984, 2961, 2860, 1728. 
(4R)-3-~(2’R,3’S,4’R,5’R)-2’,4’-dimethyl-3’,5’-di(t-butyl- 
dimethylsiloxy)-heptanoyl]-4-benzyl-2-oxazolidinone 
To a stirred solution of (4R)-3-propionyl-4-benzyl-2-oxazolidinone 
(0.373 g, 1.6 mmol, 1.75 eq.) in dry CH,CI, (9 ml) at 0°C under nitro- 
gen was added 1.55 ml of Bu,BOTf (1.0 M in CH,CI,, 1.55 mmol, 
1.7 eq.) followed by the addition of 0.35 ml of diisopropylethylamine 
(1.73 mmol, 1.9 eq.). The solution was kept stirring at 0°C for 50 min. 
After the solution was cooled to -78°C for 30 min, (2R,3R)-2-methyl- 
3-(f-butyldimethylsiloxy)pentanal (209 mg, 0.91 mmol, 1 eq.) was 
added neat (plus a lml CH,CI, wash). The resulting solution was 
stirred for 2 h at -78°C and 1.5 h at 0°C and then quenched with 1 M 
NaOAc in 90% methanol/H,0 (8 ml). After 5 min, 1.6 ml of 30% H,O, 
was added dropwise and the mixture was left to stir at ambient temper- 
ature for 30 min. The mixture was partitioned between 48 ml H,O and 
64 ml hexanes and the organic layer was washed (aqueous NaHCO,, 
brine), dried (Na,SO,) and concentrated. Purification by SiO, flash 
chromatography (5-l 5% EtOAclhexanes) gave the product, (4R)-3- 
[(2’R,3’S,4’R,5’R)-2’-4’-dimethyl-3’-hydroxy-5’-(f-butyldimethylsiloxy)- 
heptanoyll-4-benzyl-2-oxazolidinone, as a clear 011 (280 mg, 94%) plus 
62 mg of recovered aldehyde. This material was used immediately rn 
the next protection step. 
To a stirred solution of (4R)-3-[(2’R,3’S,4’R,5’R)-2’-4’-drmethyl-3’- 
hydroxy-5’-(t-butyldimethylsiloxy)-heptanoyll-4-benzyl-2-oxazolidinone 
(280 mg, 0.61 mmol, 1 eq.) in dry CH,CI, (8 ml) was added 2,6-luti- 
dine (0.115 ml, 0.98 mmol, 1.6 eq.) at 0°C. TBDMSOTf (0.21 ml, 
0.915 mmol, 1.5 eq.) was added in one portion and the reaction 
mixture was left to stir at ambient temperature for 12 h. The reaction 
was quenched with brine and the separated organic layer was washed 
with aqueous NaHCO,, brine, dried (Na,SO,) and concentrated. Punfr- 
cation by SiO, flash chromatography (5+10% EtOAclhexanes) gave 
the title compound as a colorless oil (260 mg, 74%): R, = 0.42 (15% 
EtOAc/hexanes, stains blue with vamllin) ‘H NMR (CDCI,): 6 7.34. 
7.21 (m, 5H, Ph-H,), 4.64-4.58 (m, 1 H, N-CH), 4.34 (dd, 1 H, J= 1.4 and 
6.24 Hz, C(3)-H), 4.14-4.08 (m, 2H, OCH,), 4.03-3.99 (m, 1 H, C(2’)-H), 
3.55-3.51 (m, lH, C(5’)-H), 3.48-3.44 (dd, lH, J=3.27 and 13.1 1 Hz, 
one of the Ph-CH,), 2.62-2.55 (dd, 1 H, J= 10.93 and 13.07 Hz, one 
of Ph-CH,), 1.84-l .80 (m, 1 H, C(4’)-H), 1.48-l .42 (m, 2H, C(6’)-H,), 
1 .16 (d, 3H, J= 7.03 Hz, C(2’)-CH,), 0.91-0.80 (m, 24H, 2Sr(C(CH,),, 
C(7’)-H, and C(4’)-CH,), 0.1 O-0.0 (ss, 12H, PSi(CH,),). 
(2R,3S,4R,5R)-2,4-Dimethyl-3,5-dihydroxy-n-heptanoic acid 
S lactone 13 
To a stirring solution of the diprotected imide (158 mg, 0.274 mmol, 
1 eq.) in THF (4.6 ml) and H,O (1.5 ml) at 0°C was added 30% aqueous 
H,O, (0.26 ml, 2.19 mmol, 8 eq.) followed by the addition of LiOH-H,O 
(23 mg, 0.548 mmol, 2 eq.). The resulting solution was warmed to room 
temperature overnight (12-13 h). The reaction was quenched by the 
addition of 20% aqueous Na,SO, (2.4 ml). The THF was removed in 
vacua and the aqueous layer was acidified wrth 1 N HCI and extracted 
with CH,CI, (4x25 ml). The organic layers were combined, dried 
(Na,SO,) and concentrated. The crude acid was purified by SiO, flash 
chromatography (20% EtOAc/hexanes) to grve the product (105 mg, 
92%). This was immediately subjected to deprotectron. 
The free acid (105 mg, 0.25 mmol, 1 eq.) was dissolved In a mrxture of 
acetonitrile (6.1 ml) and H,O (2.3 ml). Aqueous HF solutron (49%, 
1.6 ml) was added dropwise to the stirred solutron. The reaction was 
kept at ambient temperature overnight (12 h) and then quenched by 
dropwise addition of saturated NaHCO, solutron. The mixture was 
extracted with CH,CI, (3 x 10 ml). The combined organic layers were 
dried (Na,SO,) and concentrated. SiO, flash chromatography (50% 
EtOAc/hexanes) afforded a colorless oil (40 mg, 93%): R,= 0.28 (50% 
EtOAclhexanes, stains blue with vanillin). ‘H NMR (CDCI,): 6 1.05 (t, 
J= 7.4 Hz, 3H, H-7) 1.07 (d, J= 7.4 Hz, 3H, C(4)-CH,), 1.27 (d, J= 7.4 
Hz, 3H, C(P)-CH,), 1.59-1.68 (m, lH, one of C(6)-H,), 1.76-1.88 (m, 
2H, C(4)-H, one of C(6)-H,), 3.74-3.81 (m, 2H, C(5)-H and C(3)-H). r3C 
NMR CDCI,: 6 9.4 (C-7) 1 1.2 (C+CH,), 14.2 (C-2-CH,), 26.2 (C-6), 
39.0 (C-4) 41.8 (C-2) 75.9 (C-3) 82.6 (C-5), 174.2 (C-l). 
25’C[oIo = +82.2 (c 1 .19, CHCI,), HRMS (Cl, isobutane) [M+Hl+ calc’d 
for C,H,,O,: 173.1177, found: 173.1 178. 
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